Date post: | 03-Jun-2018 |
Category: |
Documents |
Upload: | susan-hepzi |
View: | 219 times |
Download: | 0 times |
of 29
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
1/29
HIV and Pregnancy: Prevention of
Mother-to-Child Transmission
Advances in Maternal and Neonatal Health
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
2/29
2HIV and Pregnancy
Session Objectives
To discuss best practice for antenatal, intrapartum andpostpartum care of the HIV-positive mother to reduce mother-to-child transmission
To review the evidence supporting these practices
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
3/29
3HIV and Pregnancy
HIV-Related Counseling Issues
During PregnancyEducate/counsel regarding HIV and pregnancy beforepregnancy:
Impact of HIV on pregnancy and pregnancy on HIV
Maternal health
Long-term health of mother and care for children
Perinatal transmission
Use of antiretrovirals and other drugs in pregnancy
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
4/29
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
5/29
5HIV and Pregnancy
Adverse Pregnancy Outcomes and
Relationship to HIV InfectionPregnancy Outcome Relationship to HIV Infection
Spontaneous abortion Limited data, but evidence of possible increasedrisk
Stillbirth No association noted in developed countries;evidence of increased risk in developingcountries
Perinatal mortality No association noted in developed countries, butdata limited; evidence of increased risk indeveloping countries
Newborn mortality Limited data in developed countries; evidence ofincreased risk in developing countries
Intra-uterine growthretardation
Evidence of possible increased risk
Anderson 2001.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
6/29
6HIV and Pregnancy
Adverse Pregnancy Outcomes and
Relationship to HIV Infection (continued)Pregnancy Outcome Relationship to HIV Infection
Low birth weight Evidence of possible increased risk
Preterm delivery Evidence of possible increased risk, especially w/more advanced disease
Pre-eclampsia No data
Gestational diabetes No data
Amnionitis Limited data; more recent studies do not suggestan increased risk; some earlier studies foundincreased histologic placental inflammation,particularly in those with preterm deliveries
Oligohydramnios Minimal data
Fetal malformation No evidence of increased risk
Anderson 2001.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
7/29
7HIV and Pregnancy
Mother-to-Child Transmission
25 35% of HIV positive pregnant mothers will pass HIV to theirnewborns
In the absence of breastfeeding:
30% of transmission in utero
70% of transmission during the delivery
Meta-analysis showed 14% transmission withbreastfeeding and 29% transmission with acute maternal
HIV infection or recent seroconversion
DeCock et al 2000; Dunn et al 1992; WHO/UNAIDS 1999.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
8/29
8HIV and Pregnancy
Risk Factors for Mother-to-Child
TransmissionViral load (HIV-RNA level)
Genital tract viral load
CD4 cell countClinical stage of HIV
Unprotected sex with multiplepartners
Smoking cigarettes
Substance abuseVitamin A deficiency
STDs and other coinfections
Antiretroviral agents
Preterm deliveryPlacental disruption
Invasive fetal monitoring
Duration of membrane rupture
Vaginal delivery vs. cesarean
sectionBreastfeeding
Anderson 2001.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
9/29
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
10/29
10HIV and Pregnancy
HIV Testing during Pregnancy
Advantages:
Possible treatment of mother
Reduce risk of mother-to-child transmissionFuture family planning issues
Precautions against further spread
If negative, advise about HIV prevention
Counseling is important!
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
11/29
11HIV and Pregnancy
Antenatal Care
Most HIV-infected women will be asymptomatic
Watch for signs/symptoms of AIDS and pregnancy-relatedcomplications
Unless complication develops, no need to increase number ofvisits
Treat STDs and other coinfections
Counsel against unprotected intercourse
Avoid invasive procedures and external cephalic versionGive antiretroviral agents, if available
Counsel about nutrition
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
12/29
12HIV and Pregnancy
Antiretrovirals
Zidovudine (ZDV):
Long course
Short courseNevirapine
ZDV/lamivudine (ZDV/3TC)
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
13/29
13HIV and Pregnancy
ZDV Perinatal Transmission Prophylaxis
Regimen: ACTG 076 TrialAntepartum Initiation at 14 34 weeks gestation and continued
throughout pregnancyPACTG 076 regimen: ZDV 5 times daily
Acceptable alternative regimen: ZDV 2 or 3 timesdaily (depending on dose)
Intrapartum During labor, ZDV IV over 1 hour, followed by acontinuous infusion of IV until delivery
Postpartum Oral administration of ZDV to newborn for first 6
weeks of life, beginning at 8 12 hours after birth
Anderson 2000.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
14/29
14HIV and Pregnancy
Intrapartum vs. Postpartum Regimensfor HIV-Infected Women in Labor with
No Prior Antiretroviral TherapyDrug
RegimenMaternal
IntrapartumNewborn
PostpartumData on
Transmission
Nevirapine One oraldose at onsetof labor
One oral dose atage 48 72 hours (ifmother receivednevirapine < 1 hourbefore delivery,newborn given oralnevirapine as soonas possible afterbirth and at 48 72hours)
Transmission at 6weeks 12% withnevirapinecompared to 21%with ZDV, a 47%(95% CI, 20 64%)reduction
Anderson 2001.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
15/29
15HIV and Pregnancy
Intrapartum vs. Postpartum Regimensfor HIV-Infected Women in Labor with
No Prior Antiretroviral Therapy (contd.) Drug
RegimenMaternal
IntrapartumNewborn
PostpartumData on
Transmission
ZDV/3TC ZDV orally atonset of laborfollowed bydose orallyevery 3 hoursuntil deliveryAND
3TC orally atonset of labor,followed bydose orallyevery 12 hours
ZDV orally every12 hours
AND
3TC orally every12 hours for 7days
Transmission at6 weeks 10%with ZDV/3TCcompared to17% withplacebo, a 38%reduction
Anderson 2001.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
16/29
16HIV and Pregnancy
Intrapartum vs. Postpartum Regimensfor HIV-Infected Women in Labor with
No Prior Antiretroviral Therapy (contd.) Drug
RegimenMaternal
IntrapartumNewborn
PostpartumData on
Transmission
ZDV IV bolus, followedby continuousinfusion of everyhour until delivery
Orally every 6hours for 6weeks
Transmission10% with ZDVcompared to27% with no ZDVtreatment, a 62%(95% CI, 19-82%)reduction
Anderson 2001.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
17/29
17HIV and Pregnancy
Intrapartum vs. Postpartum Regimensfor HIV-Infected Women in Labor with
No Prior Antiretroviral Therapy (contd.) Drug
RegimenMaternal
IntrapartumNewborn
PostpartumData on
Transmission
ZDV andNevirapine
IV bolus, thencontinuousinfusion untildeliveryANDNevirapine singleoral dose atonset of labor
Orally every 6hours for 6weeksANDNevirapine singleoral dose at age48 72 hours
No data
Anderson 2001.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
18/29
18HIV and Pregnancy
Obstetric Procedures
Because of increased fetal exposure to infected maternal bloodand secretions, increased transmission may come from:
Amniotomy
Fetal scalp electrode/sampling
Forceps/vacuum extractor
Episiotomy
Vaginal tears
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
19/29
19HIV and Pregnancy
Delivery: Cesarean vs. Vaginal Birth
Risk of mother-to-child transmission increased 2% each hourafter membranes have been ruptured
Cesarean section before labor and/or rupture of membranesreduces risk of mother-to-child transmission by 50 80%compared with other modes of delivery in women on noantiretroviral therapy or on ZDV alone
No evidence of benefit with cesarean section after onset oflabor or membranes have been ruptured
Cesarean section, however, increases morbidity and possiblemortality to mother
Give antibiotic prophylaxis for cesarean section in HIV-infectedwomen
International Perinatal HIV Group 1999;Semprini 1995.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
20/29
20HIV and Pregnancy
Recommended Infection
Prevention PracticesNeedles:
Take care! Minimal use
Suturing: Use appropriate needle and holderCare with recapping and disposal
Wear gloves, wash hands with soap immediately after contactwith blood and body fluids
Cover incisions with watertight dressings for first 24 hours
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
21/29
21HIV and Pregnancy
Recommended Infection
Prevention Practices (continued)Use:
Plastic aprons for delivery
Goggles and gloves for delivery and surgeryLong gloves for placenta removal
Dispose of blood, placenta and waste safely
PROTECT YOURSELF!
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
22/29
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
23/29
23HIV and Pregnancy
Breasfeeding Issues
Warmth for newborn
Nutrition for newborn
Protection against other infectionsSafety unclean water, diarrheal diseases
Risk of HIV transmission
Contraception for mother
Cost
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
24/29
24HIV and Pregnancy
Breastfeeding Recommendations
If the woman is:
HIV-negative or does not know her HIV status, promoteexclusive breastfeeding for 6 months
HIV-positive and chooses to use replacements feedings,counsel on the safe and appropriate use of formula
HIV-positive and chooses to breastfeed, promote exclusivebreastfeeding for 6 months
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
25/29
25HIV and Pregnancy
South Africa Breastfeeding Trial:
Objective and DesignObjective: To assess whether pattern of breastfeeding is acritical determinant of early mother-to-child transmission ofHIV
549 HIV-infected women studied
Compared newborns at 3 months that had been:
Exclusively breastfed
Breastfed and formula-fed
Never breastfed
Coutsoudis et al 1999.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
26/29
26HIV and Pregnancy
South Africa Breastfeeding Trial:
Results and ConclusionRisk of transmission in:
156 newborns who were never breastfed: 18.8% (95% CI12.6 24.9)
288 newborns who were breastfed and formula fed: 24.1%(95% CI 19.0 29.2)
103 newborns who were exclusively breastfed: 14.6 (95% CI7.7 21.4)
Conclusion: Newborns who were exclusively breastfed for atleast 3 months did not have any excess risk of HIV infectioncompared to newborns who were not breastfed
Coutsoudis et al 1999.
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
27/29
27HIV and Pregnancy
Conclusion
Voluntary counseling and testing
Antenatal, intrapartum and postpartum care to mother candecrease risk of mother-to-child transmission
Antiretroviral therapy can also reduce risk of transmission
Newborn care: Feeding
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
28/29
8/12/2019 HIV and Pregnancy Prevention of Mother-To-Child Transmission
29/29
29HIV and Pregnancy
References (continued)
International Perinatal HIV Group. 1999. The mode of delivery and the riskof vertical transmission of human immunodeficiency virus type 1. N Engl JMed 340(14): 977 987.Mandelbrot L et al. 1996. Obstetric factors and mother-to-childtransmission of human immunodeficiency virus type 1: The Frenchperinatal cohorts. Am er J Obs te t Gynecol 175(3 pt 1): 661 667.Semprini AE et al. 1995. The incidence of complications after cesareansection in 156 women. AIDS 9:913 917.Shaffer N et al. 1999. Short-course ZDV for perinatal HIV-1 transmission inBangkok, Thailand: A randomized controlled trial. Lancet 353: 773 780.
Sperling RS et al. 1996. Maternal viral load, ZDV treatment, and the risk oftransmission of HIV type 1 from mother to infant. N Engl J Med 335(22):1621 1629.UNICEF/UNAIDS/WHO Technical Consultation on HIV and Infant Feeding.1998. HIV and Infant Feeding: Implem entation o f Guidelines . WHO:Geneva.World Health Organization (WHO)/Joint United Nations Programme onHIV/AIDS (UNAIDS). 1999. HIV In Pregn ancy : A Review . WHO/UNAIDS:
Geneva